Smartphone-based ultrasound maker Mobisante raises $4.2M to grow sales
The mobile health company that developed the first U.S. Food and Drug Administration-cleared ultrasound imaging system that works on a smartphone is looking to boost its uptake with a $4.2 million series A. Mobisante announced the first closing of series A financing from WRF Capital, the W Fund and a group of angel investors, including […]